The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Effectiveness of an ‘half elemental diet’ as maintenance therapy for Crohn's disease: a randomized-controlled trial
Abstract
BACKGROUND: Although thiopurines have a proven role in maintenance therapy for Crohn's disease, an alternative therapy is needed for patients intolerant or resistant to thiopurines. AIM: To evaluate the effectiveness of home enteral nutrition as a maintenance therapy regimen in which half of the daily calorie requirement is provided by an elemental diet and the remaining half by a free diet. We refer to this home enteral nutrition therapy as 'half elemental diet'. METHODS: Between 2002 and 2005, 51 patients in remission from two hospitals were randomly assigned to a half elemental diet group (n = 26) or a free diet group (n = 25). The primary outcome measure of this study was the occurrence of relapse over the 2-year period. RESULTS: The relapse rate in the half elemental diet group was significantly lower [34.6% vs. 64.0%; multivariate hazard ratio 0.40 (95% CI: 0.16-0.98)] than that in the free diet group after a mean follow-up of 11.9 months. Compliance was similar in the two groups. No adverse event occurred in any of the patients throughout the study. CONCLUSION: This randomized-controlled trial shows the effectiveness of an half elemental diet, which is a promising maintenance therapy for Crohn's disease patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These diets are also effective in maintaining remission78.”
From Diet and the Intestinal Microbiome: Associations, Functions, and Implications for Health and Disease (2014) · cites this paper as [78]
Citations
Cites
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
Hanauer, S. B., Feagan, B. G., Lichtenstein, G. R., Mayer, L., Schreiber, S., Colombel, J., Rachmilewitz, D., Wolf, D. C., Olson, A. D., Bao, W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08512-4 · Cited by 4,164
Development of a Crohn's Disease Activity Index
Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976) · Gastroenterology · doi:10.1016/s0016-5085(76)80163-1 · Cited by 3,152
Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.
Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976) · PubMed · Cited by 3,147
National Cooperative Crohn's Disease Study: Results of drug treatment
Summers, R. W., Switz, D. M., Sessions, J. T., Becktel, J. M., Best, W. R., Kern, F., & Singleton, J. W. (1979) · Gastroenterology · doi:10.1016/0016-5085(79)90385-8 · Cited by 1,238
Treatment of Crohn's Disease with 6-Mercaptopurine
Present, D. H., Korelitz, B. I., Wisch, N., Glass, J. L., Sachar, D. B., & Pasternack, B. S. (1980) · New England Journal of Medicine · doi:10.1056/nejm198005013021801 · Cited by 1,024
European Cooperative Crohn's Disease Study (ECCDS): Results of drug treatment
Malchow, H. A., Ewe, K., Brandes, J. W., Goebell, H., Ehms, H., Sommer, H., & Jesdinsky, H. J. (1984) · Gastroenterology · doi:10.1016/0016-5085(84)90409-8 · Cited by 931
The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review
Fraser, A. G. (2002) · Gut · doi:10.1136/gut.50.4.485 · Cited by 631
A controlled double blind study of azathioprine in the management of Crohn's disease.
Candy, S., Wright, J., Gerber, M., Adams, G., Gerig, M., & Goodman, R. (1995) · Gut · doi:10.1136/gut.37.5.674 · Cited by 567
Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI)
Best, W. R., Becktel, J. M., & Singleton, J. W. (1979) · Gastroenterology · doi:10.1016/0016-5085(79)90384-6 · Cited by 564
Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience.
Connell, W. R., Kamm, M. A., Ritchie, J. K., & Lennard‐Jones, J. E. (1993) · Gut · doi:10.1136/gut.34.8.1081 · Cited by 495
Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine
Bouhnik, Y., Scemama, G., Taï, R., Matuchansky, C., Rambaud, J. C., Lémann, M., Modigliani, R., & Mary, J. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90402-x · Cited by 466
Meta-analysis of enteral nutrition as a primary treatment of active crohn's disease
Griffiths, A. M., Ohlsson, A., Sherman, P. M., & Sutherland, L. R. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90203-1 · Cited by 428
Clinical features and natural history of Crohn's disease
Mekhjian, H. S., Switz, D. M., Melnyk, C. S., Rankin, G. B., & Brooks, R. K. (1979) · Gastroenterology · doi:10.1016/0016-5085(79)90389-5 · Cited by 407
Lémann, M., Mary, J., Colombel, J., Duclos, B., Soulé, J., Lerebours, É., Modigliani, R., & Bouhnik, Y. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.031 · Cited by 348
DOUBLE-BLIND WITHDRAWAL TRIAL OF AZATHIOPRINE AS MAINTENANCE TREATMENT FOR CROHN'S DISEASE
O’Donoghue, D. P., Dawson, A. M., Powell-Tuck, J., Bown, R. L., & Lennard‐Jones, J. E. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92524-2 · Cited by 332
Fernández‐Bañares, F., Cabré, E., Esteve, M., & Gassull, M. A. (1995) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607195019005356 · Cited by 243
Enteral nutritional therapy for induction of remission in Crohn's disease
Zachos, M., Tondeur, M. C., & Griffiths, A. (2001) · doi:10.1002/14651858.cd000542 · Cited by 149
Corticosteroids and corticotrophin in the treatment of Crohn's disease.
Jones, J., & Lennard-Jones, J. E. (1966) · Gut · doi:10.1136/gut.7.2.181 · Cited by 137
Malignant Neoplasms Subsequent to Treatment of Inflammatory Bowel Disease With 6-Mercaptopurine
Korelitz, B. I., Mirsky, F. J., Fleisher, M. R., Warman, J. I., Wisch, N., & Gleim, G. W. (1999) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01530.x · Cited by 134
Epstein-Barr Virus–Positive Primary Gastrointestinal Hodgkin's Disease
Kumar, S., Fend, F., Quintanilla‐Martínez, L., Kingma, D. W., Sorbara, L. R., Raffeld, M. A., Banks, P. M., & Jaffe, E. S. (2000) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200001000-00008 · Cited by 126
Oral nutritional supplementation is effective in the maintenance of remission in Crohn's disease
Verma, S., Kirkwood, B. R., Brown, S., & Giaffer, M. H. (2000) · Digestive and Liver Disease · doi:10.1016/s1590-8658(00)80353-9 · Cited by 125
Hibi∥, T., Naganuma, M., Kitahora, T., Kinjyo, F., & Shimoyama, T. (2003) · Journal of Gastroenterology · doi:10.1007/s00535-003-1139-2 · Cited by 124
The Clinical Effect of Salazosulphapyridine (SalazopyrinR) in Crohn’s Disease
ANTHONISEN, P., Bárány, F., Folkenborg, O., Holtz, A., Jarnum, S., Kristensen, M., Riis, P., Walan, A., & WORNING, H. (1974) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.1974.12096873 · Cited by 106
Long-term outcome of nutritional therapy in paediatric Crohn's disease
Knight, C., El‐Matary, W., Spray, C. H., & Sandhu, B. (2005) · Clinical Nutrition · doi:10.1016/j.clnu.2005.03.005 · Cited by 96
Posthuma, E. F. M., Westendorp, R. G. J., Veer, A. V. D. S., Kluin‐Nelemans, H. C., Kluin, P. M., & Lamers, C. B. H. W. (1995) · Gut · doi:10.1136/gut.36.2.311 · Cited by 93
ANTHONISEN, P., Bárány, F., Folkenborg, O., et al. (1974) · PubMed · Cited by 89
Enteral nutrition as primary therapy in Crohn's disease.
Fernández‐Bañares, F., Cabré, E., Gónzalez‐Huix, F., & Gassull, M. À. (1994) · Gut · doi:10.1136/gut.35.1_suppl.s55 · Cited by 87
A randomized controlled study comparing elemental diet and steroid treatment in Crohn's disease
Zoli, G., CARÈ, M., Parazza, M., Spanò, C., Biagi, F., Bernardi, M., & Gasbarrini, A. (1997) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1997.t01-1-00192.x · Cited by 61
Hirakawa, H., Fukuda, Y., Tanida, N., Hosomi, M., & Shimoyama, T. (1993) · Gastroenterologia Japonica · doi:10.1007/bf02776982 · Cited by 58
Nutritional therapy in Crohn's disease
OʼSullivan, M., & O'Morain, C. A. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.3780040109 · Cited by 56
Fukuda, R., Satoh, S., Nguyễn, T. X., Uchida, Y., Kohge, N., Akagi, S., Ikeda, S., Watanabe, M., & Fukumoto, S. (1995) · Journal of Gastroenterology · doi:10.1007/bf01211373 · Cited by 48
Efficacy of nutritional therapy for active Crohn's disease.
Fukuda, Y., Kosaka, T., Okui, M., Hirakawa, H., & Shimoyama, T. (1995) · PubMed · Cited by 37
Nutritional Therapy in Crohnʼs Disease
OʼSullivan, M., & O'Morain, C. A. (1998) · Inflammatory Bowel Diseases · doi:10.1097/00054725-199802000-00008 · Cited by 32
Matsueda, K., Shoda, R., Takazoe, M., Hiwatashi, N., Bamba, T., Kobayashi, K., Saito, T., Terano, A., & Yao, T. (1995) · PubMed · Cited by 31
Self-citationAn unusual complication of immunosuppressive therapy in inflammatory bowel disease.
Khatchatourian, M., & Seaton, T. (1997) · PubMed · Cited by 26
Bowel rest and elemental diet in Crohn's disease
Moran, A. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90318-7 · Cited by 5
Flagged first, then by citations
Research works printed but not linked: 1
- Yao T, 1996, Annual Report of the Research Committee of Inflammatory Bowel Disease, 63
Cited by
Sorted by citations
Dignass, A. U., Assche, G. V., Lindsay, J. O., Lémann, M., Söderholm, J. D., Colombel, J., Danese, S., D’Hoore, A., Gassull, M. À., Gomollón, F., et al. (2010) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2009.12.002 · Cited by 1,508
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn’s disease
Ruemmele, F. M., Veres, G., Kolho, K. L., Griffiths, A., Levine, A., Escher, J. C., Amil Dias, J., Barabino, A., Braegger, C. P., Bronsky, J., et al. (2014) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2014.04.005 · Cited by 1,083
The Medical Management of Paediatric Crohn’s Disease: an ECCO-ESPGHAN Guideline Update
van Rheenen, P. F., Aloi, M., Assa, A., Bronský, J., Escher, J. C., Fagerberg, U. L., Gasparetto, M., Gerasimidis, K., Griffiths, A. M., Henderson, P., et al. (2020) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaa161 · Cited by 756
Evidence-based clinical practice guidelines for inflammatory bowel disease
Matsuoka, K., Kobayashi, T., Ueno, F., Matsui, T., Hirai, F., Inoue, N., Kato, J., Kobayashi, K., Kobayashi, K., Koganei, K., et al. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-018-1439-1 · Cited by 698
Self-citationESPEN guideline: Clinical nutrition in inflammatory bowel disease
Forbes, A., Escher, J., Hébuterne, X., Kłęk, S., Krznaric, Z., Schneider, S., Shamir, R., Stardelova, K., Wierdsma, N., Wiskin, A. E., et al. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2016.12.027 · Cited by 625
Retracted
Metadata
- Authors
- TAKAGI, S., UTSUNOMIYA, K., KURIYAMA, S., YOKOYAMA, H., TAKAHASHI, S., IWABUCHI, M., TAKAHASHI, H., TAKAHASHI, S., KINOUCHI, Y., HIWATASHI, N., FUNAYAMA, Y., SASAKI, I., TSUJI, I., & SHIMOSEGAWA, T.
- Affiliations
- Tohoku University (JP)
- Sendai Medical Center (JP)
- Iwaki Kyoritsu General Hospital (JP)
- Corresponding author
- TAKAGI, S.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2006-10-16
- Volume
- 24
- Issue
- 9
- Pages
- 1333-1340
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W2119591540
- Cited by
- 292
- References
- 36
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 22 · 2023: 11 · 2022: 9 · 2021: 18 · 2020: 21 · 2019: 25 · 2018: 19 · 2017: 22 · 2016: 16 · 2015: 16 · 2014: 18 · 2013: 12 · 2012: 18
- FWCI
- 5.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Alimentary Pharmacology & Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Nursing › Nutrition and Dietetics › Clinical Nutrition and Gastroenterology
- Health Sciences › Nursing › Nutrition and Dietetics › Dietetics, Nutrition, and Education
- Keywords
- Crohn's disease, maintenance therapy, home enteral nutrition, elemental diet, thiopurine intolerance, thiopurine resistance, relapse, remission
- MeSH terms
- Adult, Crohn Disease, Enteral Nutrition, Female, Follow-Up Studies, Food, Formulated, Humans, Male, Parenteral Nutrition, Recurrence, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
